The U.S. Food and Drug Administration has granted approval to Otsuka’s newly developed injectable therapy for patients diagnosed with primary immunoglobulin A nephropathy (IgAN), ...
Why Cancer Patients Should Eat Less Sugar: The Hidden Link Between Sugar and Tumor GrowthMany cancer patients are told by doctors to “avoid sugar.” But why?Sugar is not poison—b...
The U.S. Food and Drug Administration (FDA) has officially approved Novartis’ latest gene replacement therapy, Itvisma, marking a significant milestone in the treatment landscape ...
Treatment of type 1 diabetes (T1D) is entering a transformative era. The first immunotherapy approved to delay clinical onset—Teplizumab—has received FDA approval in the United S...